4
Changes in Ownership
Dare Bioscience, Inc. Filed Acc 0001535596-26-000002
Options or other derivatives
- Chief Accounting Officer acquired 49,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Haring-Layton MarDee Chief Accounting Officer | 2026-01-30 | Grant or award · Employee Stock Option (right to buy) | +49,000 | 49,000 | D | ||
Loading xslF345X05/wk-form4_1770066346.xml…